What is the share price of Prism Medico and Pharmacy Ltd (PRISMMEDI) today?
The share price of PRISMMEDI as on 2nd March 2026 is ₹27.36. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Prism Medico and Pharmacy Ltd (PRISMMEDI) share?
The past returns of Prism Medico and Pharmacy Ltd (PRISMMEDI) share are- Past 1 week: 15.44%
- Past 1 month: 56.97%
- Past 3 months: 51.24%
- Past 6 months: 67.24%
- Past 1 year: 72.84%
- Past 3 years: -16.48%
- Past 5 years: 0.40%
What are the peers or stocks similar to Prism Medico and Pharmacy Ltd (PRISMMEDI)?
The peers or stocks similar to Prism Medico and Pharmacy Ltd (PRISMMEDI) include:What is the market cap of Prism Medico and Pharmacy Ltd (PRISMMEDI) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Prism Medico and Pharmacy Ltd (PRISMMEDI) is ₹16.59 Cr as of 2nd March 2026.What is the 52 week high and low of Prism Medico and Pharmacy Ltd (PRISMMEDI) share?
The 52-week high of Prism Medico and Pharmacy Ltd (PRISMMEDI) is ₹30.22 and the 52-week low is ₹11.62.What is the PE and PB ratio of Prism Medico and Pharmacy Ltd (PRISMMEDI) stock?
The P/E (price-to-earnings) ratio of Prism Medico and Pharmacy Ltd (PRISMMEDI) is -414.74. The P/B (price-to-book) ratio is 1.10.Which sector does Prism Medico and Pharmacy Ltd (PRISMMEDI) belong to?
Prism Medico and Pharmacy Ltd (PRISMMEDI) belongs to the Consumer Staples sector & Agro Products sub-sector.How to buy Prism Medico and Pharmacy Ltd (PRISMMEDI) shares?
You can directly buy Prism Medico and Pharmacy Ltd (PRISMMEDI) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Prism Medico and Pharmacy Ltd
PRISMMEDI Share Price
BSEPRISMMEDI Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
PRISMMEDI Performance & Key Metrics
PRISMMEDI Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 27.20 | 1.10 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 33.80 | 8.33 | 1.81% |
PRISMMEDI Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
PRISMMEDI Company Profile
Prism Medico and Pharmacy is engaged in wholesale and retail of straw, fodder & other animal/poultry feed technology
PRISMMEDI Forecast
PRISMMEDI Forecasts
PRISMMEDI
PRISMMEDI
Income
Balance Sheet
Cash Flow
PRISMMEDI Income Statement
PRISMMEDI Income Statement
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.04 | 2.75 | 0.24 | 0.06 | 0.29 | 0.21 | 0.08 | 1.59 | 0.52 | 0.08 | ||||||||||
| Operating & Other expenses | 0.10 | 2.55 | 0.31 | 0.15 | 0.28 | 0.22 | 0.06 | 0.94 | 0.60 | 0.09 | ||||||||||
| EBITDA | -0.06 | 0.20 | -0.07 | -0.09 | 0.01 | -0.01 | 0.02 | 0.65 | -0.08 | -0.01 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBIT | -0.06 | 0.20 | -0.07 | -0.09 | 0.01 | -0.01 | 0.02 | 0.65 | -0.08 | -0.01 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -0.06 | 0.20 | -0.07 | -0.09 | 0.01 | -0.01 | 0.02 | 0.65 | -0.08 | -0.01 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | -0.02 | -0.01 | 0.00 | 0.00 | ||||||||||
| Net Income | -0.06 | 0.20 | -0.06 | -0.09 | 0.01 | -0.01 | 0.04 | 0.66 | -0.08 | -0.01 | ||||||||||
| EPS | -0.09 | 0.31 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
PRISMMEDI Company Updates
PRISMMEDI Stock Peers
PRISMMEDI Past Performance & Peer Comparison
PRISMMEDI Past Performance & Peer Comparison
Consumer StaplesAgro Products
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Prism Medico and Pharmacy Ltd | -414.74 | 1.10 | — |
| Godrej Agrovet Ltd | 27.21 | 4.49 | 1.81% |
| Gujarat Ambuja Exports Ltd | 25.59 | 2.13 | 0.18% |
| Cian Agro Industries & Infrastructure Ltd | 84.79 | 1.73 | — |
PRISMMEDI Stock Price Comparison
Compare PRISMMEDI with any stock or ETFPRISMMEDI Holdings
PRISMMEDI Shareholdings
PRISMMEDI Promoter Holdings Trend
PRISMMEDI Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
PRISMMEDI Institutional Holdings Trend
PRISMMEDI Institutional Holdings Trend
In last 3 months, retail holding in the company has decreased by 1.94%
In last 3 months, foreign institutional holding of the company has almost stayed constant
PRISMMEDI Shareholding Pattern
PRISMMEDI Shareholding Pattern
PRISMMEDI Shareholding History
PRISMMEDI Shareholding History
smallcases containing PRISMMEDI stock
smallcases containing PRISMMEDI stock
Looks like this stock is not in any smallcase yet.
PRISMMEDI Events
PRISMMEDI Events
PRISMMEDI Dividend Trend
PRISMMEDI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
PRISMMEDI Dividend Trend
PRISMMEDI has not given any dividends in last 5 years
PRISMMEDI Dividends
PRISMMEDI Dividends
PRISMMEDI Stock News & Opinions
PRISMMEDI Stock News & Opinions
Prism Medico and Pharmacy announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 20 March 2026.Powered by Capital Market - Live
Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 23 February 2026.Powered by Capital Market - Live
Net Loss of Prism Medico & Pharmacy reported to Rs 0.01 crore in the quarter ended December 2025 as against net loss of Rs 0.01 crore during the previous quarter ended December 2024. Sales declined 66.67% to Rs 0.07 crore in the quarter ended December 2025 as against Rs 0.21 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales0.070.21 -67 OPM %-28.57-4.76 - PBDT-0.01-0.01 0 PBT-0.01-0.01 0 NP-0.01-0.01 0 Powered by Capital Market - Live
Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live
Net loss of Prism Medico & Pharmacy reported to Rs 0.08 crore in the quarter ended September 2025 as against net profit of Rs 0.01 crore during the previous quarter ended September 2024. Sales rose 72.41% to Rs 0.50 crore in the quarter ended September 2025 as against Rs 0.29 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales0.500.29 72 OPM %-20.003.45 - PBDT-0.080.01 PL PBT-0.080.01 PL NP-0.080.01 PL Powered by Capital Market - Live
Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
Prism Medico and Pharmacy announced that the 23th Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live
Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 5 September 2025.Powered by Capital Market - Live
Net profit of Prism Medico & Pharmacy reported to Rs 0.66 crore in the quarter ended June 2025 as against net loss of Rs 0.09 crore during the previous quarter ended June 2024. Sales rose 2550.00% to Rs 1.59 crore in the quarter ended June 2025 as against Rs 0.06 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1.590.06 2550 OPM %40.88-150.00 - PBDT0.65-0.09 LP PBT0.65-0.09 LP NP0.66-0.09 LP Powered by Capital Market - Live
Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 14 August 2025.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -52.5%, vs industry avg of 7.38%
Over the last 5 years, market share decreased from 0.11% to 0%